News feed on Vet Dx
Wednesday, February 23, 2022
February 23, 2022 at 09:28PM Hizentra
Product approval information is indicated for treatment of primary immunodeficiency (PI) in adults and pediatric patients 2 years of age and older.
via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/0XvMQdO
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment